AccelerComm develops customizable semiconductor IP cores for physical layer solutions in terrestrial and satellite radio access networks, focusing on channel coding and signal processing. Their technology enhances 5G network performance by minimizing latency and power consumption while maximizing throughput and capacity.

Uses computational models and generative AI to create customizable virtual patient populations and conduct in silico trials, enabling the assessment of medical device safety and efficacy without human testing. This approach reduces design failures, accelerates R&D timelines, and optimizes clinical trials by simulating diverse anatomical, physiological, and pathological conditions at scale.

The startup has developed a non-contact respiratory monitoring system that utilizes passive sensors to track a variety of respiratory symptoms and environmental metrics in a home setting. This technology enables pharmaceutical companies to enhance revenue from their products while optimizing and scaling clinical studies with objective, real-time data.

Bitfount provides a federated AI and data science platform enabling secure collaboration across life sciences and clinical research organizations. The platform allows algorithms to run directly on distributed data sources, such as imaging and EHR systems, without requiring data extraction or sharing. This facilitates faster patient recruitment, site feasibility analysis, and cross-silo AI development while maintaining data privacy and security behind the firewall.

Cambridge Electric Cement develops a novel process to produce the reactive component of cement without generating emissions. This technology allows for the decarbonization of cement production within the constraints of existing industrial processes. The company offers a pathway to significantly reduce the carbon footprint associated with cement manufacturing.

Cambridge GaN Devices develops enhancement-mode GaN transistors that operate with standard silicon gate drivers, eliminating the need for costly external driving interfaces. Their technology addresses the inefficiencies of traditional silicon devices by enabling higher switching frequencies and reducing energy losses by up to 50%, resulting in smaller and more efficient consumer electronics.

CavGene Therapeutics is developing AAV-based RNA interference therapies to target specific L-type calcium channel isoforms in the brain, aimed at preventing levodopa-induced dyskinesia in patients with Parkinson's disease. This approach seeks to enhance patient quality of life and reduce caregiver burden associated with debilitating motor complications.

Charco Neurotech develops non-invasive wearable devices that employ neuromodulation technology to manage chronic pain and enhance mobility in patients with neurological disorders. Their products deliver measurable pain relief and improved functional outcomes for individuals with conditions such as Parkinson's disease and multiple sclerosis.

Concr provides predictive modeling solutions using advanced computational methods derived from astrophysics to accurately forecast individual and cohort responses to cancer therapies. This technology enhances the design of clinical trials and improves the probability of success for novel cancer treatments, particularly in early-stage trials and rare cancers.

Covatic utilizes on-device algorithms to enable privacy-focused, addressable advertising without collecting or processing personal data. This technology allows media companies to create targeted ad segments while minimizing regulatory risks and enhancing user trust.

The startup develops a quantum-driven cybersecurity platform that generates unique, unforgeable cryptographic keys using principles of quantum physics and advanced cryptography, eliminating the need for key storage. This technology ensures robust end-to-end security for IoT devices, protecting client privacy against unauthorized access.

DeepForm provides a patented fold‑flow metal forming technology that replaces traditional stamping, delivering up to 90% material utilisation and reducing waste and CO₂ emissions by up to 40%. The system integrates as a drop‑in tool within existing press lines, requiring only a single tool change while maintaining automotive‑grade quality and enabling high‑volume production for OEMs and Tier‑1 suppliers across automotive, heavy‑goods, and packaging sectors.

Echopoint Medical's iKor™ platform utilizes optical sensing technology to provide real-time coronary physiology assessments, enabling interventional cardiologists to diagnose and treat patients with ischemia and no obstructive coronary artery disease. This streamlined approach enhances therapy guidance within existing workflows, improving patient outcomes in cases of ischemia without visible blockages.

Enhanc3D Genomics utilizes its GenLink3D platform to analyze the 3D organization of DNA, focusing on the impact of genetic variations in non-coding regions on disease progression. This approach enables the identification of new biomarkers and treatment targets for complex conditions such as cancer, aging, and autoimmune diseases.

Entia offers Liberty, a home-based blood monitoring solution that enables patients to conduct their own blood tests, including assessments of blood counts and liver function. This technology reduces the need for hospital visits and enhances personalized care pathways, improving patient engagement and clinical efficiency in cancer treatment.

Evoralis creates high‑efficiency enzymes that selectively depolymerise plastics such as PET, nylon, and elastane back into their original monomers, which can be repolymerised into virgin‑quality polymers for a circular plastic economy. Using a patented microfluidic ultra‑high‑throughput screening platform, the company rapidly discovers and optimises enzymes on real plastic particles, enabling low‑energy, scalable recycling that can be integrated into existing recycling infrastructure. Enzyme products are sold directly or licensed with accompanying bioprocess know‑how, providing recyclers, waste‑management firms, and manufacturers in textiles, automotive, packaging and related sectors with a sustainable alternative to conventional recycling methods.

Flusso develops customizable mass flow and air velocity sensors using proprietary T-MEMS technology, which enhances measurement precision and reliability across various applications. Their solutions address the need for accurate flow measurement in industries such as automotive, medical, and HVAC, enabling improved energy efficiency and operational performance.

Ikarovec is a pre-clinical gene therapy company developing targeted treatments for diabetic macular edema and other common eye diseases through gene transfer techniques that introduce therapeutic DNA into ocular cells. This approach aims to provide long-lasting benefits with a single injection, reducing the need for frequent treatments and addressing the risk of vision loss.

Illumion provides charge photometry technology to deliver real-time, single-particle insights into battery material behavior. This capability accelerates materials discovery and electrode optimization for anode and cathode components. The resulting data helps developers create higher-performance, longer-lasting energy storage solutions.

Koalaa develops comfortable, lightweight, and affordable soft-sleeve prosthetics for adults and children with upper body limb differences. These modular devices enable users to perform a wide range of daily living and active sports activities. The company focuses on enhancing accessibility and supporting patient recovery through innovative prosthetic solutions.

Labs develops human-enhancement technologies that utilize artificial intelligence, immersive realities, and consumer-wearables to foster community engagement and improve individual capabilities. The company addresses the need for interconnected social experiences and sustainable practices by providing tools that empower users to learn, create, and collaborate effectively.

The startup develops modular aeroponic irrigation systems that utilize intelligent control technology to enhance the efficiency of indoor farming. Their nozzle-free, fully automatable systems eliminate the need for pesticides, significantly lowering operational costs and reducing the carbon footprint associated with fresh produce cultivation.

Mark provides a unified commerce platform that integrates physical and digital sales channels, allowing businesses to manage operations, track performance metrics, and engage customers through automated CRM tools. This solution addresses the challenge of fragmented sales processes by centralizing data and streamlining customer interactions, enhancing productivity and decision-making for small and medium enterprises.

MeVitae provides ethical AI and people science solutions to enhance workforce decision-making across the HR lifecycle. Their platform offers tools for anonymized recruiting, talent screening, resume parsing, and people analytics to improve fairness and efficiency. The company integrates these capabilities into hiring automation and reporting suites to deliver data-driven workforce insights.